Very late relapse cases of TCF3-ZNF384-positive acute lymphoblastic leukemia. 2019

Akira Nishimura, and Daisuke Hasegawa, and Shinsuke Hirabayashi, and Shoichiro Kanabuchi, and Kaoru Yamamoto, and Saori Aiga, and Misa Nishitani, and Yosuke Hosoya, and Yasushi Noguchi, and Kentaro Ohki, and Nobutaka Kiyokawa, and Shinichiro Mori, and Atsushi Manabe
Department of Pediatrics, St. Luke's International Hospital, Tokyo, Japan.

UI MeSH Term Description Entries
D012008 Recurrence The return of a sign, symptom, or disease after a remission. Recrudescence,Relapse,Recrudescences,Recurrences,Relapses
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D003131 Combined Modality Therapy The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used. Multimodal Treatment,Therapy, Combined Modality,Combined Modality Therapies,Modality Therapies, Combined,Modality Therapy, Combined,Multimodal Treatments,Therapies, Combined Modality,Treatment, Multimodal,Treatments, Multimodal
D005091 Exons The parts of a transcript of a split GENE remaining after the INTRONS are removed. They are spliced together to become a MESSENGER RNA or other functional RNA. Mini-Exon,Exon,Mini Exon,Mini-Exons
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000971 Antineoplastic Combined Chemotherapy Protocols The use of two or more chemicals simultaneously or sequentially in the drug therapy of neoplasms. The drugs need not be in the same dosage form. Anticancer Drug Combinations,Antineoplastic Agents, Combined,Antineoplastic Chemotherapy Protocols,Antineoplastic Drug Combinations,Cancer Chemotherapy Protocols,Chemotherapy Protocols, Antineoplastic,Drug Combinations, Antineoplastic,Antineoplastic Combined Chemotherapy Regimens,Combined Antineoplastic Agents,Agent, Combined Antineoplastic,Agents, Combined Antineoplastic,Anticancer Drug Combination,Antineoplastic Agent, Combined,Antineoplastic Chemotherapy Protocol,Antineoplastic Drug Combination,Cancer Chemotherapy Protocol,Chemotherapy Protocol, Antineoplastic,Chemotherapy Protocol, Cancer,Chemotherapy Protocols, Cancer,Combinations, Antineoplastic Drug,Combined Antineoplastic Agent,Drug Combination, Anticancer,Drug Combination, Antineoplastic,Drug Combinations, Anticancer,Protocol, Antineoplastic Chemotherapy,Protocol, Cancer Chemotherapy,Protocols, Antineoplastic Chemotherapy,Protocols, Cancer Chemotherapy
D014411 Neoplastic Stem Cells Highly proliferative, self-renewing, and colony-forming stem cells which give rise to NEOPLASMS. Cancer Stem Cells,Colony-Forming Units, Neoplastic,Stem Cells, Neoplastic,Tumor Stem Cells,Neoplastic Colony-Forming Units,Tumor Initiating Cells,Cancer Stem Cell,Cell, Cancer Stem,Cell, Neoplastic Stem,Cell, Tumor Initiating,Cell, Tumor Stem,Cells, Cancer Stem,Cells, Neoplastic Stem,Cells, Tumor Initiating,Cells, Tumor Stem,Colony Forming Units, Neoplastic,Colony-Forming Unit, Neoplastic,Initiating Cell, Tumor,Initiating Cells, Tumor,Neoplastic Colony Forming Units,Neoplastic Colony-Forming Unit,Neoplastic Stem Cell,Stem Cell, Cancer,Stem Cell, Neoplastic,Stem Cell, Tumor,Stem Cells, Cancer,Stem Cells, Tumor,Tumor Initiating Cell,Tumor Stem Cell,Unit, Neoplastic Colony-Forming,Units, Neoplastic Colony-Forming
D015514 Oncogene Proteins, Fusion The GENETIC TRANSLATION products of the fusion between an ONCOGENE and another gene. The latter may be of viral or cellular origin. Chimeric Oncogene Proteins,Chimeric Proteins, Oncogene,Fusion Proteins, Oncogene,Oncogene Fusion Proteins,Oncogene Proteins, Chimeric,Fusion Oncogene Proteins,Oncogene Chimeric Proteins,Proteins, Chimeric Oncogene,Proteins, Fusion Oncogene,Proteins, Oncogene Chimeric,Proteins, Oncogene Fusion
D016026 Bone Marrow Transplantation The transference of BONE MARROW from one human or animal to another for a variety of purposes including HEMATOPOIETIC STEM CELL TRANSPLANTATION or MESENCHYMAL STEM CELL TRANSPLANTATION. Bone Marrow Cell Transplantation,Grafting, Bone Marrow,Transplantation, Bone Marrow,Transplantation, Bone Marrow Cell,Bone Marrow Grafting

Related Publications

Akira Nishimura, and Daisuke Hasegawa, and Shinsuke Hirabayashi, and Shoichiro Kanabuchi, and Kaoru Yamamoto, and Saori Aiga, and Misa Nishitani, and Yosuke Hosoya, and Yasushi Noguchi, and Kentaro Ohki, and Nobutaka Kiyokawa, and Shinichiro Mori, and Atsushi Manabe
April 2004, Haematologica,
Akira Nishimura, and Daisuke Hasegawa, and Shinsuke Hirabayashi, and Shoichiro Kanabuchi, and Kaoru Yamamoto, and Saori Aiga, and Misa Nishitani, and Yosuke Hosoya, and Yasushi Noguchi, and Kentaro Ohki, and Nobutaka Kiyokawa, and Shinichiro Mori, and Atsushi Manabe
July 2015, Leukemia & lymphoma,
Akira Nishimura, and Daisuke Hasegawa, and Shinsuke Hirabayashi, and Shoichiro Kanabuchi, and Kaoru Yamamoto, and Saori Aiga, and Misa Nishitani, and Yosuke Hosoya, and Yasushi Noguchi, and Kentaro Ohki, and Nobutaka Kiyokawa, and Shinichiro Mori, and Atsushi Manabe
January 2007, Leukemia & lymphoma,
Akira Nishimura, and Daisuke Hasegawa, and Shinsuke Hirabayashi, and Shoichiro Kanabuchi, and Kaoru Yamamoto, and Saori Aiga, and Misa Nishitani, and Yosuke Hosoya, and Yasushi Noguchi, and Kentaro Ohki, and Nobutaka Kiyokawa, and Shinichiro Mori, and Atsushi Manabe
September 1998, Haematologica,
Akira Nishimura, and Daisuke Hasegawa, and Shinsuke Hirabayashi, and Shoichiro Kanabuchi, and Kaoru Yamamoto, and Saori Aiga, and Misa Nishitani, and Yosuke Hosoya, and Yasushi Noguchi, and Kentaro Ohki, and Nobutaka Kiyokawa, and Shinichiro Mori, and Atsushi Manabe
October 2014, Pediatric hematology and oncology,
Akira Nishimura, and Daisuke Hasegawa, and Shinsuke Hirabayashi, and Shoichiro Kanabuchi, and Kaoru Yamamoto, and Saori Aiga, and Misa Nishitani, and Yosuke Hosoya, and Yasushi Noguchi, and Kentaro Ohki, and Nobutaka Kiyokawa, and Shinichiro Mori, and Atsushi Manabe
June 2010, Pediatrics international : official journal of the Japan Pediatric Society,
Akira Nishimura, and Daisuke Hasegawa, and Shinsuke Hirabayashi, and Shoichiro Kanabuchi, and Kaoru Yamamoto, and Saori Aiga, and Misa Nishitani, and Yosuke Hosoya, and Yasushi Noguchi, and Kentaro Ohki, and Nobutaka Kiyokawa, and Shinichiro Mori, and Atsushi Manabe
June 2018, Leukemia & lymphoma,
Akira Nishimura, and Daisuke Hasegawa, and Shinsuke Hirabayashi, and Shoichiro Kanabuchi, and Kaoru Yamamoto, and Saori Aiga, and Misa Nishitani, and Yosuke Hosoya, and Yasushi Noguchi, and Kentaro Ohki, and Nobutaka Kiyokawa, and Shinichiro Mori, and Atsushi Manabe
February 2018, Epigenomics,
Akira Nishimura, and Daisuke Hasegawa, and Shinsuke Hirabayashi, and Shoichiro Kanabuchi, and Kaoru Yamamoto, and Saori Aiga, and Misa Nishitani, and Yosuke Hosoya, and Yasushi Noguchi, and Kentaro Ohki, and Nobutaka Kiyokawa, and Shinichiro Mori, and Atsushi Manabe
January 2023, Cancer control : journal of the Moffitt Cancer Center,
Akira Nishimura, and Daisuke Hasegawa, and Shinsuke Hirabayashi, and Shoichiro Kanabuchi, and Kaoru Yamamoto, and Saori Aiga, and Misa Nishitani, and Yosuke Hosoya, and Yasushi Noguchi, and Kentaro Ohki, and Nobutaka Kiyokawa, and Shinichiro Mori, and Atsushi Manabe
August 2022, JCO precision oncology,
Copied contents to your clipboard!